3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
164
Lung Neoplasms
61
Small Cell Lung Carcinoma
24
Neoplasms
10
NSCLC
9
Mesothelioma, Malignant
9
Breast Neoplasms
8
Pancreatic Neoplasms
7
Ovarian Neoplasms
7
Melanoma
6
Head and Neck Neoplasms
6
Colorectal Neoplasms
6
Esophageal Neoplasms
5
Stomach Neoplasms
4
Neoplasm Metastasis
4
Mesothelioma
4
Kidney Neoplasms
4
Brain Neoplasms
4
Sarcoma
3
Pleural Effusion, Malignant
3
Liver Neoplasms
3
Fallopian Tube Neoplasms
3
Cholangiocarcinoma
3
Carcinoma
3
Adenocarcinoma of Lung
3
Uterine Cervical Neoplasms
2
Thymus Neoplasms
2
Thymoma
2
Small Cell Lung Cancer Limited Stage
2
Skin Neoplasms
2
Interventions
Vinorelbine
1
Gemcitabine
1
Drug Therapy
1
Cisplatin
1
Cilengitide
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metatropic dwarfism
×
Drug Therapy
×
Thoracic
×
Clear all
NCT00842712
2017-01-13
CERTO
Merck KGaA, Darmstadt, Germany
Phase 2
Completed
232 enrolled
17 charts